News and updates
Company news, industry analysis and relevant scientific literature.
Qana presents at San Antonio’s BioFest Invest 2024
Senior Scientist, Dr. Christian Boada, represented Qana at the BioFest Invest Pitch Competition in...
Qana Therapeutics receives NIH (NCI) Innovative Concept Award to advance a novel therapeutic for adrenocortical carcinoma
Award will fund development of Qana's metabolically-targeted therapeutic for adrenocortical...
Qana closes new funding from leading mid-continent seed stage investor
Proprietary delivery platform, based on endogenous human cholesterol transport, offers the...
Rutledge Cancer Foundation invests in Qana Therapeutics’s Ewing sarcoma program
Collaborative preclinical study with Dr. Jason Yustein of Emory University funded by the Rutledge...